Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Bristol Myers Squibb Company

Highlights

A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 85
» View baltimoresun.com items only
    Jul 16, 2012 |Story| Baltimore Sun
  1. GlaxoSmithKline to acquire Human Genome Sciences

    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...

    Tags: Amylin Pharmaceuticals Incorporated, Immune System, Food and Drug Administration, Medical Research, Companies and Corporations

  2. Jun 27, 2002 |Story| Associated Press
  3. Oct 15, 2002 |Story| Associated Press
  4. Oct 15, 2002 |Story| Associated Press
  5. May 15, 2005 |Story| Baltimore Sun
  6. Many executives delivered 'bang for the buck'

    Sun Staff
    For 2004, a year that saw the shares of T. Rowe Price Group Inc. surge more than 31 percent, company chief executive George A. Roche received a more modest 21.7 percent bump in his compensation - just about all from performance bonuses. In short, a half-...

    Tags: T. Rowe Price, Shareholders, Stock Broking, CEO Pay, Corporate Performance

  7. Mar 3, 2003 |Story| Baltimore Sun
  8. Md. bill targets gifts to doctors

    Sun Staff
    Maryland lawmakers are considering clamping down on the fancy meals, theater tickets and expensive trips lavished on doctors by pharmaceutical companies trying to persuade health care professionals to prescribe their medications. "The system bothers me,"...

    Tags: American Medical Association, Maryland, Medical Services, Lobbying, Baltimore County

  9. May 16, 2013 |Story| Reuters
  10. STOCKS NEWS US-Total option open interest stands at 2.74 mln contracts

    Reuters
    Real-time equity news [E U] U.S. stock market report 0940 ET 16May2013 Total option open interest stands at 2.74 mln contracts -------------------------------------------------------------------------------- A total of 19.8 million contracts changed...

    Tags: Cisco Systems Inc., Bank of America Corp., Barrick Gold Corporation

  11. May 15, 2013 |Story| Reuters
  12. Bristol-Myers shares jump ahead of melanoma trial data

    Reuters
    By Doris Frankel and David Gaffen CHICAGO/NEW YORK, May 15 (Reuters) - Shares of drugmaker Bristol-Myers Squibb Co rose to a ten-year high on Wednesday ahead of results of an early stage trial for its new melanoma treatment, with heavy betting in the...

    Tags: Oncology, Annual and Special Corporate Meetings, Skin Cancer

  13. May 15, 2013 |Story| Reuters
  14. Bristol melanoma drug combo marks new advance in immunotherapy

    Reuters
    (For more stories on new cancer data, see ) By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance...

    Tags: Food and Drug Administration, Medical Specialization, Renal cell carcinoma, Lung Cancer, Medical Research

  15. May 15, 2013 |Story| Reuters
  16. Roche immunotherapy shows response over range of cancers

    Reuters
    By Bill Berkrot May 15 (Reuters) - An experimental Roche Holding AG drug that helps the immune system attack tumors was well tolerated and demonstrated an impressive effect against a variety of cancers, according to preliminary trial results released on...

    Tags: New Haven (New Haven, Connecticut), Medical Specialization, Renal cell carcinoma, Lung Cancer, Medical Research

  17. May 8, 2013 |Story| Reuters
  18. U.S. spending on medicines fell for first time in 2012

    (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday.
    Reuters
    (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday. Overall U.S....

    Tags: Patient Protection and Affordable Care Act, Flu, Seroquel (drug), Plavix (drug), Pfizer Inc.

  19. May 9, 2013 |Story| Reuters
  20. Spending on drugs falls for first time in 55 years

    The amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic.
    Reuters
    The amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...

    Tags: Prescription Drugs, AstraZeneca Plc, Patient Protection and Affordable Care Act, Plavix (drug), Statins (drugs)

 1  2 3 4 5 6 7 8Next >
Original site for Bristol Myers Squibb Company topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Bristol Myers Squibb Company Photos
Ivonne Cabrera has been promoted to senior vice preside...
(January 23, 2013)
Ivonne Cabrera, general counsel, Dover
Lucie Howell, of Avon, has been named director of Quinn...
(May 28, 2012)
Lucie Howell
California Insurance Commissioner Dave Jones announces...
(March 18, 2011)